PFG Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $279K | Sell |
3,561
-1,860
| -34% | -$150K | 0.01% | 678 |
|
|
2026
Q1 | $470K | Buy |
5,421
+682
| +14% | +$65.3K | 0.02% | 559 |
|
|
2025
Q4 | $455K | Sell |
4,739
-2,161
| -31% | -$210K | 0.02% | 551 |
|
|
2025
Q3 | $657K | Buy |
6,900
+489
| +8% | +$45K | 0.03% | 487 |
|
|
2025
Q2 | $559K | Buy |
6,411
+2,267
| +55% | +$192K | 0.03% | 397 |
|
|
2025
Q1 | $372K | Buy |
4,144
+1,471
| +55% | +$132K | 0.02% | 541 |
|
|
2024
Q4 | $214K | Buy |
2,673
+208
| +8% | +$18K | 0.01% | 659 |
|
|
2024
Q3 | $222K | Sell |
2,465
-521
| -17% | -$43.8K | 0.01% | 661 |
|
|
2024
Q2 | $235K | Buy |
2,986
+232
| +8% | +$19K | 0.02% | 614 |
|
|
2024
Q1 | $240K | Sell |
2,754
-7,592
| -73% | -$648K | 0.02% | 580 |
|
|
2023
Q4 | $852K | Sell |
10,346
-1,285
| -11% | -$97.9K | 0.07% | 295 |
|
|
2023
Q3 | $911K | Sell |
11,631
-1,334
| -10% | -$112K | 0.08% | 263 |
|
|
2023
Q2 | $1.14M | Sell |
12,965
-389
| -3% | -$33.5K | 0.09% | 261 |
|
|
2023
Q1 | $1.08M | Buy |
13,354
+275
| +2% | +$22.4K | 0.09% | 265 |
|
|
2022
Q4 | $1.02M | Sell |
13,079
-2,191
| -14% | -$178K | 0.1% | 245 |
|
|
2022
Q3 | $1.23M | Buy |
15,270
+1,687
| +12% | +$152K | 0.14% | 189 |
|
|
2022
Q2 | $1.22M | Buy |
13,583
+412
| +3% | +$41.7K | 0.14% | 145 |
|
|
2022
Q1 | $1.46M | Buy |
13,171
+1,057
| +9% | +$112K | 0.15% | 150 |
|
|
2021
Q4 | $1.25M | Buy |
12,114
+1,388
| +13% | +$161K | 0.12% | 207 |
|
|
2021
Q3 | $1.34M | Buy |
10,726
+92
| +0.9% | +$11.9K | 0.15% | 193 |
|
|
2021
Q2 | $1.32M | Buy |
10,634
+673
| +7% | +$84.5K | 0.15% | 187 |
|
|
2021
Q1 | $1.18M | Buy |
9,961
+3,000
| +43% | +$352K | 0.15% | 186 |
|
|
2020
Q4 | $815K | Sell |
6,961
-1,490
| -18% | -$164K | 0.14% | 194 |
|
|
2020
Q3 | $893K | Buy |
8,451
+1,702
| +25% | +$171K | 0.17% | 155 |
|
|
2020
Q2 | $613K | Buy |
6,749
+250
| +4% | +$24K | 0.14% | 182 |
|
|
2020
Q1 | $660K | Buy |
6,499
+385
| +6% | +$41K | 0.18% | 148 |
|
|
2019
Q4 | $712K | Buy |
6,114
+75
| +1% | +$8.23K | 0.17% | 150 |
|
|
2019
Q3 | $645K | Buy |
6,039
+180
| +3% | +$18.8K | 0.18% | 153 |
|
|
2019
Q2 | $601K | Buy |
5,859
+130
| +2% | +$11.9K | 0.16% | 165 |
|
|
2019
Q1 | $509K | Sell |
5,729
-166
| -3% | -$14.9K | 0.16% | 174 |
|
|
2018
Q4 | $532K | Buy |
+5,895
| New | +$551K | 0.17% | 165 |
|
Other funds holding MDT
FWIA
SRIM
DC
ECSS
CAI
VF
PFG Advisors's MDT Position: Q2 2026 in Review
PFG Advisors reduced its Medtronic (MDT) stake by 34% in Q2 2026, selling an estimated $150K and leaving 3,561 shares worth $279K. The position accounts for 0.01% of the portfolio, ranked #678.
PFG Advisors first reported a position in MDT in Q4 2018 and has held it in 31 quarters since. The position peaked at $1.46M in Q1 2022. 814 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- PFG Advisors held 3,561 shares of Medtronic worth $279K as of Q2 2026.
- PFG Advisors sold 1,860 Medtronic shares in Q2 2026, an estimated $150K.
- Medtronic made up 0.01% of PFG Advisors's portfolio in Q2 2026, its #678 holding.
- PFG Advisors first reported a position in Medtronic in Q4 2018 and has held it in 31 quarters since.
- PFG Advisors's Medtronic position peaked at $1.46M in Q1 2022.
- 814 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on PFG Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.